The company has made more than 50 deals for its proprietary technology as it looks forward to a potentially “transformative” ...

Lenacapavir is a multistage, selective inhibitor of HIV-1 capsid function that directly binds to the interface between capsid protein (p24) subunits in hexamers. Surface plasmon resonance sensorgrams ...